ALDH7A1 and neoplasm: A novel approach to anti-tumor therapy is to modulate cAMP and cGMP with PDE inhibitors as cAMP and cGMP are negative regulators of cell growth and aberrant signaling has been shown to play an important role in various carcinomas and hematological malignancies [7], [9].